Earnings Feed
Start Free
Home/Filings/4/0000850693-03-000042
4//SEC Filing

ALLERGAN INC 4

Accession 0000850693-03-000042

CIK 0000850693operating
View on SEC.govCompany Profile

Filed

Nov 2, 7:00 PM ET

Accepted

Nov 3, 7:53 PM ET

Size

8.9 KB

Accession

0000850693-03-000042

Insider Transaction Report

Form 4
Period: 2003-10-30
ALLERGAN INC(AGN)
FELLOWS DAVID A
CVP, Pres., EuroAsia/Africa/ME
Transactions
  • Sale

    Common Stock

    2003-10-30$76.06/sh−21,520$1,636,897→ 8,986.41 total
  • Exercise/Conversion

    Common Stock

    2003-10-30$13.01/sh+21,520$279,889→ 30,506.41 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2003-10-30$76.06/sh−21,520$1,636,897→ 0 total
    Exercise: $13.01Exp: 2007-04-22→ Common Stock (21,520 underlying)
Holdings

  • Common Stock

    (indirect: By Spouse)
    2,314.775

  • Common Stock

    (indirect: By Trust)
    3,497.71

  • Common Stock

    (indirect: By Trust)
    6,332.405
Footnotes (2)
  • [F1]Includes phantom stock units accrued under the Allergan, Inc. Dividend Reinvestment Plan.
  • [F2]Nonqualified stock option granted 4/22/97 under the issuer's incentive compensation plan, which option vested ratably over 4 years from the date of grant.

Documents

1 file

Issuer

ALLERGAN INC

CIK 0000850693

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000850693

Filing Metadata

Form type
4
Filed
Nov 2, 7:00 PM ET
Accepted
Nov 3, 7:53 PM ET
Size
8.9 KB
View on SEC.gov